scholarly journals Reduced serum osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome components in postmenopausal women: the crosstalk between bone and energy metabolism

2012 ◽  
Vol 30 (6) ◽  
pp. 683-691 ◽  
Author(s):  
Ali Movahed ◽  
Bagher Larijani ◽  
Iraj Nabipour ◽  
Mohammadreza Kalantarhormozi ◽  
Kamyar Asadipooya ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Metabolic Syndrome ◽  
Type 2 Diabetes Mellitus ◽  
Energy Metabolism ◽  
Postmenopausal Women ◽  
Serum Osteocalcin ◽  
The Metabolic Syndrome ◽  
Metabolic Syndrome Components

Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women

Metabolism ◽  
2010 ◽  
Vol 59 (5) ◽  
pp. 742-747 ◽  
Author(s):  
Iraj Nabipour ◽  
Mohammadreza Kalantarhormozi ◽  
Bagher Larijani ◽  
Majid Assadi ◽  
Zahra Sanjdideh
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Metabolic Syndrome ◽  
Type 2 Diabetes Mellitus ◽  
Postmenopausal Women ◽  
The Metabolic Syndrome

Predicting young-onset type 2 diabetes mellitus with metabolic syndrome components in healthy young adults

2018 ◽  
Vol 72 (9) ◽  
pp. e13238
Author(s):  
Chung-Ze Wu ◽  
Jin-Sheun Chen ◽  
Yuh-Feng Lin ◽  
Chang-Hsun Hsieh ◽  
Jiunn-Diann Lin ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Metabolic Syndrome ◽  
Type 2 Diabetes Mellitus ◽  
Young Adults ◽  
Young Onset ◽  
Onset Type ◽  
Metabolic Syndrome Components

scholarly journals Advantages of therapy with sodium glucose cotransporter type 2 inhibitors in patients with type 2 diabetes mellitus in combination with hyperuricemia and gout

2020 ◽  
Vol 92 (5) ◽  
pp. 110-118 ◽  
Author(s):  
T. S. Panevin ◽  
M. S. Eliseev ◽  
M. V. Shestakova ◽  
E. L. Nasonov
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Metabolic Syndrome ◽  
Type 2 Diabetes Mellitus ◽  
New Drugs ◽  
Positive Effects ◽  
The Metabolic Syndrome ◽  
Sodium Glucose Cotransporter ◽  
The Russian Federation

Currently, only two drugs for reducing uric acid (UA), allopurinol and febuxostat, are registered in the Russian Federation, but their use does not allow to achieve the target level of UA in all cases. According to the results of numerous randomized trials, hyperuricemia and gout are associated with the corresponding components of the metabolic syndrome, including diabetes mellitus. The influence of factors is due to the need to search for new drugs that have a complex effect on several components of metabolic syndrome at once. Potentially attractive in this regard is a new group of drugs for the treatment of type 2 diabetes mellitus inhibitors of the sodium-glucose cotransporter of type 2, which, in addition to the main hypoglycemic actions, showed positive effects on the cardiovascular system, kidneys, as well as lowering UA.

Sign in / Sign up

Export Citation Format

Share Document